These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32248704)

  • 21. The two-stage placental model of preeclampsia: An update.
    Staff AC
    J Reprod Immunol; 2019 Sep; 134-135():1-10. PubMed ID: 31301487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review.
    Ives CW; Sinkey R; Rajapreyar I; Tita ATN; Oparil S
    J Am Coll Cardiol; 2020 Oct; 76(14):1690-1702. PubMed ID: 33004135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New perspectives on preeclampsia].
    Méhats C; Miralles F; Vaiman D
    Med Sci (Paris); 2017 Dec; 33(12):1079-1088. PubMed ID: 29261496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preeclampsia: Disease biology and burden, its management strategies with reference to India.
    Malik A; Jee B; Gupta SK
    Pregnancy Hypertens; 2019 Jan; 15():23-31. PubMed ID: 30825923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years?
    Remuzzi G; Ruggenenti P
    Am J Kidney Dis; 1991 Sep; 18(3):285-305. PubMed ID: 1882820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis of preeclampsia.
    Young BC; Levine RJ; Karumanchi SA
    Annu Rev Pathol; 2010; 5():173-92. PubMed ID: 20078220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preeclampsia. Part 1: clinical and pathophysiologic considerations.
    Pridjian G; Puschett JB
    Obstet Gynecol Surv; 2002 Sep; 57(9):598-618. PubMed ID: 12218668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy.
    Obstet Gynecol; 2018 Jul; 132(1):e44-e52. PubMed ID: 29939940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative analysis of mice models for preeclampsia].
    Doridot L; Méhats C; Vaiman D
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):234-8. PubMed ID: 22626651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
    Silasi M; Cohen B; Karumanchi SA; Rana S
    Obstet Gynecol Clin North Am; 2010 Jun; 37(2):239-53. PubMed ID: 20685551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current model systems for the study of preeclampsia.
    Martinez-Fierro ML; Hernández-Delgadillo GP; Flores-Morales V; Cardenas-Vargas E; Mercado-Reyes M; Rodriguez-Sanchez IP; Delgado-Enciso I; Galván-Tejada CE; Galván-Tejada JI; Celaya-Padilla JM; Garza-Veloz I
    Exp Biol Med (Maywood); 2018 Mar; 243(6):576-585. PubMed ID: 29415560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal Models of Preeclampsia: Mechanistic Insights and Promising Therapeutics.
    Taylor EB; George EM
    Endocrinology; 2022 Aug; 163(8):. PubMed ID: 35772781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-eclampsia - The "uterine reinnervation" view.
    Quinn MJ
    Med Hypotheses; 2014 Nov; 83(5):575-9. PubMed ID: 25216751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.
    Buchbinder A; Sibai BM; Caritis S; Macpherson C; Hauth J; Lindheimer MD; Klebanoff M; Vandorsten P; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G;
    Am J Obstet Gynecol; 2002 Jan; 186(1):66-71. PubMed ID: 11810087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endothelial dysfunction: role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system].
    Calicchio R; Buffat C; Vaiman D; Miralles F
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):215-20. PubMed ID: 23721989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?
    Pierik E; Prins JR; van Goor H; Dekker GA; Daha MR; Seelen MAJ; Scherjon SA
    Front Immunol; 2019; 10():3098. PubMed ID: 32010144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular origins of preeclampsia.
    Kalafat E; Thilaganathan B
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):383-389. PubMed ID: 28961633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preeclampsia - Current Management and Future Approach.
    Dymara-Konopka W; Laskowska M; Oleszczuk J
    Curr Pharm Biotechnol; 2018; 19(10):786-796. PubMed ID: 30255751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preeclampsia and health risks later in life: an immunological link.
    Cheng SB; Sharma S
    Semin Immunopathol; 2016 Nov; 38(6):699-708. PubMed ID: 27339196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.